An immunoaffinity-purified Trypanosoma cruzi antigen suppresses cellular proliferation through a TGF-β-mediated mechanism

Scandinavian Journal of Immunology

Volumn 47, Issue 5, 1998, Pages 509-516

  Hansen, D S ^a,b   Villacres Eriksson, M ^c   Akerblom L ^b   Hellman, U ^d   Segura, E ^a   Carlomagno, M ^a   Morein, B ^b,c  

^a Instituto Nacional de Diagnostico e Investigacion de la Enfermedad de Chagas Dr Mario Fatala Chaben   (Argentina)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTIGEN; CONCANAVALIN A; MONOCLONAL ANTIBODY; OLIGOPEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHAGAS DISEASE; EPIMASTIGOTE; FEMALE; IMMUNE DEFICIENCY; IMMUNOAFFINITY CHROMATOGRAPHY; INFECTION RISK; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TRYPANOSOMA CRUZI;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, PROTOZOAN; CHROMATOGRAPHY, AFFINITY; CONCANAVALIN A; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLAGELLA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PEPTIDE HYDROLASES; PEPTIDES; SPLEEN; SUBCELLULAR FRACTIONS; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CRUZI;

EID: 0031745663     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00340.x     Document Type: Article

References (38)

1. Minoprio PM, Eisen H, Forni L, D'Imperio Lima MR, Joskowicz M Coutinho A. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantification of both T and B cell responses. Scand J Immunol 1986;24:661-8.
2. Ortiz-Ortiz L, Parks DE, Rodriguez M, Weigle WO. Polyclonal B lymphocyte activation during T. cruzi infection. J Immunol 1980;124:121-6.
3. Plata F. Enhancement of tumor growth correlates with suppression of tumor-specific cytolytic T lymphocyte response in mice chronically infected by Trypanosoma cruzi. J Immunol 1985;134:1312-9.
4. Reed SG, Roters SB, Goidl EA. Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice. J Immunol 1983;131:1978-82.
5. Tarleton RL. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2 producing cells. J Immunol 1988;140:2763-8.
6. Kierzenbaum F, Sztein MB. Trypanosma cruzi suppresses the expression of p75 chain of interleukin-2 receptor on the surface of activated helper and cytotoxic human lymphocytes. Immunol 1992;75:546-9.
7. Rottenberg M, Lindquist C, Koman A, Segura EL, Örn A. Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine Trypanosoma cruzi infection. Scand J Immunol 1989;30:65-72.
8. Sztein MB, Kierzenbaum F. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes. Immunol 1992;77:277-83.
9. Silva JS, Morrissey JP, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992;175:169-74.
10. Silva JS, Twardzik DR, Reed SG. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J Exp Med 1991;174:539-45.
11. Snary D. The cell surface of Trypanosoma cruzi. Curr Top Microb Immunol 1985;117:75-92.
12. Ruiz A, Esteva M, Cabeza Meckert P, Laguens R, Segura EL. Protection and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi. Acta Trop 1985;42:299-309.
13. Ruiz A, Esteva M, Riarte A, Sub'as E, Segura EL. Immunoprotection of mice against Trypanosoma cruzi with a lyophilized flagellar fraction of the parasite plus adjuvant. Immunol Lett 1986;12:1-4.
14. Araujo F, Morein B. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice. Infect Immun 1991;59:2909-14.
15. Hansen DS, Alievi G, Segura EL, Carlomagno M, Morien B, Villacres-Eriksson M. The flagellar fraction of Trypanosoma cruzi depleted of an immunosuppressive antigen enhances protection to infection and elicits spontaneous T cell responses. Parasite Immunol 1996;18:607-5.
16. Laemli JK. Cleavage of stuctural proteins during assembly of the head bacteriophage T4. Nature 1970;277:680-5.
17. Towbin H, Staehelin T, Gordin J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-3.
18. Hellman U, Wernstedt C, Góñez LJ, Heldin C-H. Improvement of an 'in -gel' digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal Biochem 1995;224:451-5.
19. Roberts AB, Sporn MB. The transforming growth factor-betas. In: Sporn MB and Robert AB, eds. Peptide Growth Factors and their Receptors. Handbook of Experimental Pharmacology. Heidelberg: Springer-Verlag, 1990: 419-72.
20. Johnson HM, Russell JK, Pontzer CH. Staphylococcal enterotoxin superantigens. Proc Soc Exp Biol Med 1991;198:765-71.
21. Piuvezam MR, Russo DM, Burns JJ, Skeiky YA, Grabstein KH, Reed SG. Characterization of responses of normal human T cells to Trypanosoma cruzi antigens. J Immunol 1993;150:916-24.
22. Van Voorhis WC. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J Immunol 1992;148:239-48.
23. Pestel J, Defoort JP, Gras MH, Afchain D, Capron A, Tartar A, Ouaissi A. Polyclonal cell activity of a repeat peptide derived from the sequence of an 85-kilodalton surface protein of Trypanosoma cruzi trypomastigotes. Infect Immun 1992;60:715-9.
24. Ouaissi MA, Defort JP, Afchain D, Gras-Masse H, Cornette J, Caron H, Tartar A, Capron A. Use of synthetic peptides in two different approaches to interfere with host cell penetration by Trypanosoma cruzi. UCLA Symp Mol Cell Biol New Ser 1989;86:43.
25. Mejia Lopez H, Tanner MK, Kierszenbaum F, Sztein MB. Alterations induced by Trypanosoma cruzi in activated mouse lymphocytes. Parasite Immunol 1993;15:273-80.
26. Holter W, Kalthoff FS, Pickl WF, Ebner C, Majdic O, Kraft D, Knapp W. Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells. Int Immunol 1994;6:469-75.
27. Ming M, Ewn ME, Pereira MEA. Trypanosome invasion of mammalian cells requires of the TGF-β signalling pathway. Cell 1995;82:287-96.
28. Zhang L, Tarleton RL. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol 1996;26:102-9.
29. Buamah PK, Harris R, James OFW, Skillen AW. Lentil-lectin-reactive alpha-fetoprotein in the differential diagnosis of benign and malignant liver disease. Clin Chem 1986;32:2083-4.
30. Sell S, Becker FF. Alpha-fetoprotein. J Natl Cancer Ins 1978;60:19-26.
31. Vasella RL, Santrach MA, Bronson D, Smith CJP, Klicka MJ, Lange PH. Evaluation of AFP glycosylation heterogeneity in cancer patiens with AFP-producing tumors. Int J Cancer 1984;34:309-14.
32. Murgita RA. The immunosuppressive role of alpha-fetoprotein during pregnancy. Scand J Immunol 1976;5:1003-14.
33. Chakraborty M, Mandal C. Immuno-suppressive effect of human alphafetoprotein: a cross species study. Immunol Invest 1993;22: 329-339.
34. Cohen BL, Örn A, Grönvik KO, Gidlund M, Wigzell H, Murgita RA. Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin-2. Scand J Immunol 1986;23:211-23.
35. O'Neil G, Tsega E, Gold P, Murgita RA. Evidence for selective suppression of Ia-associated T-cell proliferation in vitro. Oncodev Biol Med 1982;3:135-50.
36. Susuki Y, Seng CQ, Alpert E. Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes. J Clin Invest 1992;90:1530-6.
37. Torres JM, Laborda J, Naval J, Darracq N, Calvo M, Mishal Z, Uriel ??. Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation. J Molec Immunol 1989;26:851-7.
38. Altman DJ, Schneider SL, Thompson DA, Cheng HL, Tomasi TB. A transforming growth factor beta 2 (TGF-beta-2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta-2 mRNA in pregnant uterus. J Exp Med 1990;172:1391-401.